Mono steroid treatment

An elevation in serum bilirubin level of more than 2 times ULN with associated transaminase rise is an ominous sign. This indicates severe hepatotoxicity and is likely to lead to mortality in 10% to 15% of patients, especially if the offending drug is not stopped ( Hy's Law ). [43] [44] This is because it requires significant damage to the liver to impair bilirubin excretion, hence minor impairment (in the absence of biliary obstruction or Gilbert syndrome ) would not lead to jaundice. Other poor predictors of outcome are old age, female sex, high AST . [45] [46]

Mono steroid treatment

mono steroid treatment

Media:

mono steroid treatmentmono steroid treatmentmono steroid treatmentmono steroid treatmentmono steroid treatment